- Name: Chen Yingbo
- Title: Deputy Director, Chief physician and advisor of master’s degree students
Prof. Chen has been engaged in medical treatment, scientific research and teaching in the Department of Abdominal Surgery at Sun Yat-sen University Cancer Center since 1992. Through the 20 years of medical practices, he has mastered the fundamental theories of oncology and basic surgical techniques and accumulated rich clinical experience in diagnosis and treatment of gastrointestinal tumor. Especially he has been well experienced in lymph node dissection for various radical surgeries of gastric cancer, the digestive tract reconstruction after radical full-stomach & proximal gastrectomy for gastric carcinoma as well as laparoscopic D2 radical gastrectomy for gastric carcinoma.
1992-1997: Resident physician, Department of Abdominal Surgery at Sun Yat-sen University Cancer Center;
1997-2004: Attending physician, Department of Abdominal Surgery at Sun Yat-sen University Cancer Center;
2004-2011: Associate chief physician, Department of Abdominal Surgery at Sun Yat-sen University Cancer Center;
2011-present: Chief physician, Department of Gastric and Pancreatic Surgery at Sun Yat-sen University Cancer Center.
1986-1992: Undergraduate, Department of Medicine at Sun Yat-sen University of Medical Sciences;
1996-1999: Master’s degree student of Oncology at Sun Yat-sen University of Medical Sciences;
2010: Advanced studies in Melanoma Institute Australia, Sydney.
1. Comparison of transthoracic and transabdominal surgical approaches for the treatment of adenocarcinoma of the cardia，Chinese journal of cancer，2010，29（8）
2．No Survival Benefit From Postoperative Adjuvant Chemotherapy After D2 Radical Resection for the Patients With Stage II Gastric Cancer， American Journal of Clinical Oncology，2011，
3．Mast cells in the adjacent normal colon mucosa rather than those in the invasive margin are related to the progression of colon cancer ，Chinese Journal of Cancer Research，2011,23(4)
4．Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinoma, Journal of Surgical Oncology, 2011
5. Serosa-penetration in human T4aN0M0 gastric carcinoma correlates with worse prognosis after D2 gastrectomy，Chinese Medical Journal，2012
6. Eficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy, Oncology Letters，2012